Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 37

1.

Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study.

Kugathasan S, Denson LA, Walters TD, Kim MO, Marigorta UM, Schirmer M, Mondal K, Liu C, Griffiths A, Noe JD, Crandall WV, Snapper S, Rabizadeh S, Rosh JR, Shapiro JM, Guthery S, Mack DR, Kellermayer R, Kappelman MD, Steiner S, Moulton DE, Keljo D, Cohen S, Oliva-Hemker M, Heyman MB, Otley AR, Baker SS, Evans JS, Kirschner BS, Patel AS, Ziring D, Trapnell BC, Sylvester FA, Stephens MC, Baldassano RN, Markowitz JF, Cho J, Xavier RJ, Huttenhower C, Aronow BJ, Gibson G, Hyams JS, Dubinsky MC.

Lancet. 2017 Mar 1. pii: S0140-6736(17)30317-3. doi: 10.1016/S0140-6736(17)30317-3. [Epub ahead of print]

PMID:
28259484
2.

Characterizing the inflammatory response in esophageal mucosal biopsies in children with eosinophilic esophagitis.

Sayej WN, Ménoret A, Maharjan AS, Fernandez M, Wang Z, Balarezo F, Hyams JS, Sylvester FA, Vella AT.

Clin Transl Immunology. 2016 Jul 1;5(7):e88. doi: 10.1038/cti.2016.30. eCollection 2016 Jul.

3.

The Gut Microbiome and Probiotics.

Fatima A, Sylvester FA.

Adolesc Med State Art Rev. 2016 Spring;27(1):140-54. Review. No abstract available.

PMID:
27363238
4.

The ABCs (and Ds) of Bone Imaging in Children With Crohn Disease.

Sylvester FA.

J Pediatr Gastroenterol Nutr. 2016 Jul;63(1):4-5. doi: 10.1097/MPG.0000000000001145. No abstract available.

PMID:
26859087
5.
6.

Cloning and variation of ground state intestinal stem cells.

Wang X, Yamamoto Y, Wilson LH, Zhang T, Howitt BE, Farrow MA, Kern F, Ning G, Hong Y, Khor CC, Chevalier B, Bertrand D, Wu L, Nagarajan N, Sylvester FA, Hyams JS, Devers T, Bronson R, Lacy DB, Ho KY, Crum CP, McKeon F, Xian W.

Nature. 2015 Jun 11;522(7555):173-8. doi: 10.1038/nature14484. Epub 2015 Jun 3.

7.

The Telehealth Enhancement of Adherence to Medication (TEAM) in pediatric IBD trial: Design and methodology.

Hommel KA, Gray WN, Hente E, Loreaux K, Ittenbach RF, Maddux M, Baldassano R, Sylvester F, Crandall W, Doarn C, Heyman MB, Keljo D, Denson LA.

Contemp Clin Trials. 2015 Jul;43:105-13. doi: 10.1016/j.cct.2015.05.013. Epub 2015 May 21.

8.

Reply: To PMID 24976330.

Chicaiza H, Hellstrand K, Lerer T, Smith S, Sylvester F.

J Pediatr. 2015 Mar;166(3):781-2. doi: 10.1016/j.jpeds.2014.11.050. Epub 2015 Jan 9. No abstract available.

PMID:
25578995
9.

Effects of exclusive enteral nutrition on bone mass, linear growth and body composition in children with Crohn's disease.

Sylvester FA.

Nestle Nutr Inst Workshop Ser. 2014;79:125-30. doi: 10.1159/000360717. Epub 2014 Sep 5.

PMID:
25227300
10.

Distinctive colonic mucosal cytokine signature in new-onset, untreated pediatric Crohn disease.

Sylvester FA, Draghi A, Menoret A, Fernandez ML, Wang Z, Vella AT.

J Pediatr Gastroenterol Nutr. 2014 Nov;59(5):553-61. doi: 10.1097/MPG.0000000000000480.

PMID:
25000355
11.

Potassium hydroxide: an alternative reagent to perform the modified apt test.

Chicaiza H, Hellstrand K, Lerer T, Smith S, Sylvester F.

J Pediatr. 2014 Sep;165(3):628-30. doi: 10.1016/j.jpeds.2014.05.027. Epub 2014 Jun 26.

PMID:
24976330
12.

Bone health in children and adolescents with chronic diseases that may affect the skeleton: the 2013 ISCD Pediatric Official Positions.

Bianchi ML, Leonard MB, Bechtold S, Högler W, Mughal MZ, Schönau E, Sylvester FA, Vogiatzi M, van den Heuvel-Eibrink MM, Ward L; International Society for Clinical Densitometry..

J Clin Densitom. 2014 Apr-Jun;17(2):281-94. doi: 10.1016/j.jocd.2014.01.005. Epub 2014 Mar 19.

PMID:
24656723
13.

The treatment-naive microbiome in new-onset Crohn's disease.

Gevers D, Kugathasan S, Denson LA, Vázquez-Baeza Y, Van Treuren W, Ren B, Schwager E, Knights D, Song SJ, Yassour M, Morgan XC, Kostic AD, Luo C, González A, McDonald D, Haberman Y, Walters T, Baker S, Rosh J, Stephens M, Heyman M, Markowitz J, Baldassano R, Griffiths A, Sylvester F, Mack D, Kim S, Crandall W, Hyams J, Huttenhower C, Knight R, Xavier RJ.

Cell Host Microbe. 2014 Mar 12;15(3):382-92. doi: 10.1016/j.chom.2014.02.005.

14.

Report of the CCFA pediatric bone, growth and muscle health workshop, New York City, November 11-12, 2011, with updates.

Sylvester FA, Gordon CM, Thayu M, Burnham JM, Denson LA, Essers J, Ferrari S, Gupta N, Hewison M, Koletzko S, McCabe L, Pappa H, Sanderson I, Ward L, Zanotti S.

Inflamm Bowel Dis. 2013 Dec;19(13):2919-26. doi: 10.1097/MIB.0b013e3182a5a004.

PMID:
23974992
15.

[Management of colonic Crohn disease with no response to corticoids and sulfazalazine: first case of pediatric use of infliximab in Peru].

Muñoz Urribarri A, Sylvester F, Delgado Godos A, Castillo Durán R.

Rev Gastroenterol Peru. 2013 Apr-Jun;33(2):162-6. Spanish.

PMID:
23838945
16.

Medical stool: the future of treatment for inflammatory bowel disease?

Davidovics ZH, Sylvester FA.

J Pediatr Gastroenterol Nutr. 2013 Jun;56(6):583. doi: 10.1097/MPG.0b013e318295cc5a. No abstract available.

PMID:
23575302
17.

Genetic diversity in introduced golden mussel populations corresponds to vector activity.

Ghabooli S, Zhan A, Sardiña P, Paolucci E, Sylvester F, Perepelizin PV, Briski E, Cristescu ME, MacIsaac HJ.

PLoS One. 2013;8(3):e59328. doi: 10.1371/journal.pone.0059328. Epub 2013 Mar 22.

18.

Health supervision in the management of children and adolescents with IBD: NASPGHAN recommendations.

Rufo PA, Denson LA, Sylvester FA, Szigethy E, Sathya P, Lu Y, Wahbeh GT, Sena LM, Faubion WA.

J Pediatr Gastroenterol Nutr. 2012 Jul;55(1):93-108. doi: 10.1097/MPG.0b013e31825959b8.

19.
20.

Fecal osteoprotegerin may guide the introduction of second-line therapy in hospitalized children with ulcerative colitis.

Sylvester FA, Turner D, Draghi A 2nd, Uuosoe K, McLernon R, Koproske K, Mack DR, Crandall WV, Hyams JS, Leleiko NS, Griffiths AM.

Inflamm Bowel Dis. 2011 Aug;17(8):1726-30. doi: 10.1002/ibd.21561. Epub 2010 Dec 3.

PMID:
21744427

Supplemental Content

Loading ...
Support Center